Freya Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2017
- Open Charges ₹ 0.70 M
- Revenue Growth %
- Profit Growth 82.84%
- Ebitda 82.84%
- Net Worth -24.40%
- Total Assets 25.69%
About Freya Life Science
Freya Life Science Private Limited (FLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 30 December 2011 and has a history of 13 years and one month. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2017. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹0.70 M.
Priyanka Patil and Seshadrinathan Swamy serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51397PN2011PTC141822
- Company No.
141822
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2011
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
What products or services does Freya Life Science Private Limited offer?
Freya Life Science Private Limited offers a wide range of products and services, including Pharmaceutical Medicine, Bulk Drugs.
Who are the key members and board of directors at Freya Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Priyanka Patil  | Director | 30-Dec-2011 | Current |
| Seshadrinathan Swamy | Director | 30-Dec-2011 | Current |
Financial Performance of Freya Life Science.
Freya Life Science Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 82.84% increase in profit. The company's net worth observed a substantial decline by a decrease of 24.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Freya Life Science?
In 2016, Freya Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Plasma Biogenic LlpPriyanka Patil is a mutual person
Charges (Loans)
₹0.70 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of Mysore : 0.07 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Apr 2012 | State Bank Of Mysore | ₹0.70 M | Open |
How Many Employees Work at Freya Life Science?
Unlock and access historical data on people associated with Freya Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Freya Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Freya Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
